ASX ANNOUNCEMENT 20 June 2024 Radiopharm Theranostics Limited Suite 1, Level 3, 62 Lygon Street, Carlton South VIC 3053 Australia ABN: 57 647 877 889 Radiopharm Receives Strategic Investment for up to A$18 million • Lantheus has agreed to make an initial strategic equity investment of A$7.5 million in Radiopharm • Offer price for the shares of A$0.05 represents a 47% premium to the last closing price of $0.034 on 19 June 2024 • Option for Lantheus to invest a further A$7.5m within 6 months on the same terms • Lantheus will also secure rights to two early preclinical assets in exchange for an A$3m upfront payment pursuant to a transfer and development agreement
RAD Price at posting:
3.4¢ Sentiment: Buy Disclosure: Held
